Experimental models of SARS-CoV-2 infection: possible platforms to study COVID-19 pathogenesis and potential treatments

S Pandamooz, B Jurek, CP Meinung… - Annual review of …, 2022 - annualreviews.org
In December 2019, a novel coronavirus crossed species barriers to infect humans and was
effectively transmitted from person to person, leading to a worldwide pandemic …

Simplex representation of molecular structure as universal QSAR/QSPR tool

V Kuz'min, A Artemenko, L Ognichenko, A Hromov… - Structural Chemistry, 2021 - Springer
We review the development and application of the Simplex approach for the solution of
various QSAR/QSPR problems. The general concept of the simplex method and its varieties …

Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as …

K Ghosh, SA Amin, S Gayen, T Jha - Journal of Molecular Structure, 2021 - Elsevier
As the world struggles against current global pandemic of novel coronavirus disease
(COVID-19), it is challenging to trigger drug discovery efforts to search broad-spectrum …

[HTML][HTML] Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches

MA Alamri, MT ul Qamar, MU Mirza… - Journal of …, 2020 - Elsevier
The papain-like protease (PL pro) is vital for the replication of coronaviruses (CoVs), as well
as for escaping innate-immune responses of the host. Hence, it has emerged as an …

Learning from history: do not flatten the curve of antiviral research!

T Bobrowski, CC Melo-Filho, D Korn, VM Alves… - Drug Discovery …, 2020 - Elsevier
Highlights•COVID-19 has caused the most rapid research response to a pandemic in recent
history.•After epidemics end, less research is performed on the causative agent.•Except for …

Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study

S Mazzini, L Musso, S Dallavalle, R Artali - Molecules, 2020 - mdpi.com
A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has
been the cause of a recent global pandemic. The highly contagious nature of this life …

Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease

MG Santibáñez-Morán, E López-López… - RSC …, 2020 - pubs.rsc.org
The pandemic caused by SARS-CoV-2 (COVID-19 disease) has claimed more than 500 000
lives worldwide, and more than nine million people are infected. Unfortunately, an effective …

[HTML][HTML] Discovery of synergistic and antagonistic drug combinations against SARS-CoV-2 in vitro

T Bobrowski, L Chen, RT Eastman, Z Itkin, P Shinn… - BioRxiv, 2020 - ncbi.nlm.nih.gov
COVID-19 is undoubtedly the most impactful viral disease of the current century, afflicting
millions worldwide. As yet, there is not an approved vaccine, as well as limited options from …

Drug repurposing for covid-19: discovery of potential small-molecule inhibitors of spike protein-ACE2 receptor interaction through virtual screening and consensus …

S Patil, J Hofer, PJ Ballester, E Fattakhova, J DiFlumeri… - 2020 - chemrxiv.org
Objective There is an increased interest in drug repurposing against Covid-19 (SARS-CoV-
2) as its spread has significantly outpaced development of effective therapeutics. Our aim is …

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

K Ghosh, SA Amin, S Gayen, T Jha - Journal of molecular structure, 2021 - Elsevier
Fragment based drug discovery (FBDD) by the aid of different modelling techniques have
been emerged as a key drug discovery tool in the area of pharmaceutical science and …